Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
about
Informatics and standards for nanomedicine technologyThe prevention and regression of atherosclerotic plaques: emerging treatments.Biosensors in clinical chemistry: An overviewFuture of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Antibacterial activity of neem nanoemulsion and its toxicity assessment on human lymphocytes in vitro.Integration of biosensors and drug delivery technologies for early detection and chronic management of illnessGold nanoparticles - the theranostic challenge for PPPM: nanocardiology application.Acoustic cardiac signals analysis: a Kalman filter-based approach.Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.Tailoring polymersome bilayer permeability improves enhanced permeability and retention effect for bioimaging.Critical evaluation of biodegradable polymers used in nanodrugs.Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticlesTherapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis.The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.The nanomedicine revolution: part 1: emerging concepts.The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.Green synthesis of silver nanoparticles by Chrysanthemum morifolium Ramat. extract and their application in clinical ultrasound gel.Silicon micro- and nanofabrication for medicineSerum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.Visualization of bionanostructures using transmission electron microscopical techniques.Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.Nanomedicine in cardiovascular therapy: recent advancements.Upconverting and NIR emitting rare earth based nanostructures for NIR-bioimaging.Nanotechnology for the detection and therapy of stroke.Role of silver nanoparticles (AgNPs) on the cardiovascular system.The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases.Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery.Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial.Towards Precision in HF Pharmacotherapy.The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.Radiolabelled nanoparticles: novel classification of radiopharmaceuticals for molecular imaging of cancer.Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluids.The nanomedicine revolution: part 2: current and future clinical applications.Cytotoxic Activity of Highly Purified Silver Nanoparticles Sol Against Cells of Human Immune System.
P2860
Q23912034-36A33C53-D3A5-4C0A-BBB5-4CDA4E1A6073Q27691367-6E64F14C-B1F0-4A00-B9CA-736BD9A22AC2Q28657882-E4248035-2668-4589-A199-7FC4C1784BEBQ30360777-4804AD6B-7A6B-4E21-87E8-58E06D2303E8Q30364399-AED83E34-A37A-496B-82D0-498702B11CCAQ30400795-7CDC76EE-F173-4243-97B1-77E0B3577244Q30451853-D8C5BE5B-B529-4E88-B3BB-37BAF88BF98CQ30452438-2173F08D-BC6F-4D8D-99E1-D12DA9E75FDDQ30466320-5C7EC624-6C08-4CF7-AD76-6DDE0257C246Q30473970-78DE3314-1627-4477-B9C6-EA6FABC4FC75Q33893586-4007BC80-CD3A-4AF3-929B-8581F40D4131Q34976931-C9FB30E4-ABDB-4E30-BAA4-611BF58D10B6Q35174085-4CE285CA-D2B9-444A-9184-3EDC007ADEF4Q35585791-767F5C31-9638-4670-81AF-85844151E85AQ35913344-A262D9F8-1B12-4B84-A37D-8DCBBFF7E73AQ35917005-F2022390-9BF1-481F-BA9A-6751583D6056Q36292618-075E3C7E-A212-477B-BB90-9A5FAE90EED4Q36555535-983F3C5D-55CE-4F8D-BECB-DE229B809C40Q36843475-8EAE48E1-6C1D-4B93-AD4B-BCBF389C171DQ37184228-A03FE6DE-A808-484C-89C4-2EA649C3159CQ37451428-83C61D8A-1206-4D13-92A2-DAEE2D7B4C63Q37511128-12047EF5-A344-460C-B2C9-3319605E2D20Q37519622-9538B571-E7A5-4A27-884D-6646EDE519A7Q37871989-656F8E91-62D9-49AD-A27F-86DDA8349CD1Q37893578-0DAE9416-79BF-4C9C-B4E1-449EAA47601CQ38006425-933A30C6-45D9-4835-9E25-24F7A21F9E88Q38034812-FE89873D-48D6-42DC-9E91-388247DD9FC7Q38128476-6E033768-049C-4D70-8EED-8017E9BC740EQ38201415-3B8E6E96-CD4A-440F-9099-C3B6A3D2BCB0Q38301573-789CB372-88F0-4949-B757-20CF66913EAFQ38550131-66E492AA-E392-429F-92A5-85C8AB86E2DBQ38640456-BD1438C1-7A52-4627-B369-54CD5895F846Q38667602-81200D13-AA7B-4E7C-89A8-06F2294F24E6Q38758440-D5ADF069-5032-4157-8A02-356380ABEDBFQ38775962-9F0F7329-A78E-409B-8634-3C9C609EE478Q38828033-52F95EC1-B371-438B-B53E-A53CE83D5860Q38997208-B0136F1F-B057-41D1-9EE6-AC3494870B3BQ39223140-E4F32E1D-3DB0-439C-B3B6-E9BAAFD877AEQ39527453-9A194BBB-4489-453C-AC9D-77BC04F5938CQ41444937-2EAB2D82-10E0-45C9-9B81-37C81C9AD201
P2860
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Emerging applications of nanom ...... nt of cardiovascular diseases.
@ast
Emerging applications of nanom ...... nt of cardiovascular diseases.
@en
type
label
Emerging applications of nanom ...... nt of cardiovascular diseases.
@ast
Emerging applications of nanom ...... nt of cardiovascular diseases.
@en
prefLabel
Emerging applications of nanom ...... nt of cardiovascular diseases.
@ast
Emerging applications of nanom ...... nt of cardiovascular diseases.
@en
P2093
P2860
P1476
Emerging applications of nanom ...... nt of cardiovascular diseases.
@en
P2093
Alessandro Grattoni
Ali Bouamrani
Biana Godin
Jason H Sakamoto
Mauro Ferrari
Rita E Serda
P2860
P304
P356
10.1016/J.TIPS.2010.01.003
P577
2010-02-19T00:00:00Z